Eiko de Jong
Impact in
-
- Neuroinflammation and Neurodegeneration Mechanisms
-
- Neurogenesis and neuroplasticity mechanisms
Papers in
-
- Retinal Diseases and Treatments 3
- Ocular Infections and Treatments 1
- Ocular Diseases and Behçet’s Syndrome 1
-
- Atherosclerosis and Cardiovascular Diseases 1
- interferon and immune responses 1
- Complement system in diseases 1
- Co-authors
- Hilmar R. J. van Weering (1 shared paper)Hendrikus Boddeke (1 shared paper)Knut Biber (1 shared paper)Nadhim Bayatti (1 shared paper)Dina Fathalla (1 shared paper)Aniki Rothová (1 shared paper)Carel C B Hoyng (4 shared papers)Sanne K. Verbakel (1 shared paper)
- Journals
- Investigative Ophthalmology & Visual Science (3 papers)Current Drug Targets (1 paper)Kölner Universitäts PublikationsServer (Universität zu Köln) (1 paper)
- Partner nations
- NetherlandsGermanySwitzerland
In The Last Decade
Eiko de Jong
4 papers receiving 43 citations
Peers
Comparison fields: 5 of 24
- Neurology 27
- Developmental Neuroscience 4
- Cellular and Molecular Neuroscience 16
- Virology 4
- Immunology 11
Countries citing papers authored by Eiko de Jong
This map shows the geographic impact of Eiko de Jong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eiko de Jong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eiko de Jong more than expected).
Fields of papers citing papers by Eiko de Jong
This network shows the impact of papers produced by Eiko de Jong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eiko de Jong. The network helps show where Eiko de Jong may publish in the future.
Co-authors
The 25 scholars most cited alongside Eiko de Jong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 39 | |
| 2 | Factor H-Related Protein 4 (FHR-4) drives complement dysregulation in age-related macular degeneration | 2019 | 2 |
| 3 | A genetic variant in NRP1 is associated with worse response to ranibizumab treatment in neovascular age-related macular degeneration | 2015 | 1 |
| 4 | Adalimumab Therapy for Refractory Birdshot Chorioretinopathy | 2015 | 1 |
| 5 | Acetazolamide for the treatment of cystic macular lesions in children and young adults with hereditary macular dystrophies | 2016 | 0 |
About Eiko de Jong
Eiko de Jong is a scholar working on Ophthalmology, Immunology, Oncology, Radiology, Nuclear Medicine and Imaging and Neurology, having authored 5 papers that have together received 43 indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (3 papers), Atherosclerosis and Cardiovascular Diseases (1 paper), interferon and immune responses (1 paper), Antioxidant Activity and Oxidative Stress (1 paper), Ocular Infections and Treatments (1 paper), Neuroinflammation and Neurodegeneration Mechanisms (1 paper), Ocular Diseases and Behçet’s Syndrome (1 paper) and Complement system in diseases (1 paper). The work is most often cited by research in Neurology (27 citations), Developmental Neuroscience (4 citations), Cellular and Molecular Neuroscience (16 citations), Virology (4 citations) and Immunology (11 citations). Eiko de Jong has collaborated with scholars based in Netherlands, Germany and Switzerland. Frequent co-authors include Hilmar R. J. van Weering, Hendrikus Boddeke, Knut Biber, Nadhim Bayatti, Dina Fathalla, Aniki Rothová, Carel C B Hoyng, Sanne K. Verbakel, Freekje van Asten and Philipp S. Muether. Their work appears in journals such as Investigative Ophthalmology & Visual Science, Current Drug Targets and Kölner Universitäts PublikationsServer (Universität zu Köln).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.